Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryDermaSensor medical AI product profile
FDA De Novo-cleared handheld device that uses AI-enabled elastic scattering spectroscopy to help trained physicians evaluate suspicious skin lesions.
Medical imaging and radiology
Best fit
Clinician-supervised primary-care or referral workflows that need objective support for suspicious melanoma, basal cell carcinoma, or squamous cell carcinoma lesions.
- Primary use case
- AI-assisted optical spectroscopy for adjunctive skin cancer risk assessment and dermatologist referral decisions
- Audience
- Primary care physicians, dermatology referral networks, health systems, and clinical governance teams evaluating suspicious-lesion assessment workflows
- Risk level
- High
- Pricing signal
- Subscription and device terms should be verified with DermaSensor for the current region, volume, and reimbursement workflow.
- Official sources
- 4 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating DermaSensor as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as regulated prescription medical-device software and hardware; match use to DEN230008, age limits, lesion exclusions, trained users, adjunctive role, and post-market performance expectations. |
|---|---|
| Privacy | Review device connectivity, cloud synchronization, software updates, remote monitoring, identifiers, access controls, BAA terms, retention, and support workflows before clinical rollout. |
| Evidence | Assess FDA summary evidence and local pilot data for sensitivity, specificity, false reassurance, false referral, skin type, lesion location, and prevalence differences. |
| Workflow | Best governed as a suspicious-lesion referral aid where clinicians first identify eligible lesions, interpret the AI output with clinical findings, document decisions, and track biopsy or dermatology follow-up. |
Where DermaSensor fits
DermaSensor describes an FDA-cleared AI-powered skin cancer risk detection device for physicians that uses elastic scattering spectroscopy and returns Monitor or Investigate Further outputs; FDA's De Novo summary for DEN230008 states the device is an adjunctive second-read tool for suspicious lesions and is not standalone diagnosis, screening, biopsy replacement, or clinical-decision replacement.
Not for: At-home screening, standalone diagnosis, broad skin checks, lesions outside the cleared indication, or replacing dermatology referral and biopsy judgment.
What to verify before using DermaSensor
- FDA De Novo DEN230008, prescription-use limits, patient age, lesion exclusions, and whether the intended users match the cleared non-dermatologist physician workflow.
- Device training, spectral scan capture, output interpretation, referral thresholds, contraindications, warnings, and how results are documented in the record.
- Cloud synchronization, device monitoring, patient identifiers, support access, retention, BAA or privacy terms, and security review for connected-device use.
- Local performance for Fitzpatrick skin types, melanoma prevalence, prior biopsies, false negatives, false positives, referral burden, and dermatologist follow-up completion.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.dermasensor.com / skin-cancer-detection-device
- www.accessdata.fda.gov / cdrh_docs / reviews
- www.dermasensor.com / faq
- www.dermasensor.com / privacy-policy
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.